Moxifloxacin HCL 400 MG tablet UD 50S
Ended Awarded Last action
- Contract number
- SPE2DR26F3GBX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,316
Award facts
- Contract value 100% obligated
- $1,315.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $1,315.97 delivery order to Amerisourcebergen Drug Corp on May 8, 2026, for moxifloxacin HCL 400 mg tablet UD 50s, with an ultimate completion date of May 11, 2026.
Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside used.
Quick answers
Who was awarded contract SPE2DR26F3GBX?
SPE2DR26F3GBX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 8, 2026.
How much is contract SPE2DR26F3GBX worth?
The government has obligated $1,316 on SPE2DR26F3GBX.
Is contract SPE2DR26F3GBX an order under another contract?
Yes. SPE2DR26F3GBX is a delivery order under SPE2DR25D7005, an indefinite delivery contract.
Was contract SPE2DR26F3GBX competed?
The extent of competition for SPE2DR26F3GBX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award